2015 – 2025 GLOBAL NUCLEAR MEDICINE MARKET FORECAST & OPPORTUNITIES
www.techsciresearch.com MARKET INTELLIGENCE . CONSULTING
Scope of Report Product of Interest (POI): Nuclear Medicine
Global nuclear medicine market is expected to witness impressive growth rate during the forecast period owing to increasing incidences and prevalence of diseases like cancer, etc., initiatives to reduce the demand and supply gap of Mo-99 and increasing research and development activities in radiotherapy to treat various diseases. Furthermore, nuclear medicines are extensively being used in molecular imaging, which is a technique involving molecules as biomarkers for specific molecular processes that determine the onset or progress of a disease. Nuclear medicines are convenient and safer alternative for patients as compared to X-Rays and other external radiation imaging devices.
Market Segmentation THERAPY
THERAPEUTICS
APPLICATION
•
Alpha Particle Emitters
•
Beta Particle Emitters
•
Auger Electron Emitters
•
Radioactive Iodine
•
Cardiology
•
Radioactive Antibodies
•
Respiratory
•
Radioactive Phosphorus
•
Orthopaedics
•
Oral
•
Other Radioactive Substances
•
Neurology
•
Intravenous
•
Oncology
•
Nasal
•
Urology
TYPE •
REGION
SPECT (Single Photo Emission Computed Tomography)
ROUTE OF ADMINISTRATION
END-USER
•
PET (Positron Emission Tomography)
•
Alpha-emitters
•
Hospitals
•
Beta-emitters
•
Diagnostic Centers
•
Brachytherapy
•
Others
•
North America
•
Europe
•
Middle East & Africa
•
Asia-Pacific
•
South America
Year Range Review Period
2015 – 2018 Base Year
2019 Estimated Year
2020 Forecast Period
2021 – 2025
2
Table of Contents S. No.
Contents
1.
Product Overview
2.
Research Methodology
3.
Executive Summary
4.
Voice of Customer
5.
Global Nuclear Medicine Market Outlook 5.1.
Market Size & Forecast 5.1.1.
5.2.
5.3. 6.
Page No.
By Value & Volume
Market Share & Forecast 5.2.1.
By Therapy (Radioactive Iodine, Radioactive Antibodies, Radioactive Phosphorus, Other Radioactive Substances)
5.2.2.
By Type (SPECT (Single Photo Emission Computed Tomography), PET (Positron Emission Tomography), Alpha-emitters, Beta-emitters, Brachytherapy)
5.2.3.
By Application (Cardiology, Respiratory, Orthopaedics, Neurology, Oncology, Urology)
5.2.4.
By Therapeutics (Alpha Particle Emitters, Beta Particle Emitters, Auger Electron Emitters)
5.2.5.
By Route of Administration (Oral, Intravenous, Nasal)
5.2.6.
By End-User (Hospitals, Diagnostic Centers, Others)
5.2.7.
By Company (2019)
5.2.8.
By Region (North America, Europe, Asia-Pacific, South America and Middle East & Africa)
Market Attractiveness Index
Asia-Pacific Nuclear Medicine Market Outlook 6.1.
Market Size & Forecast
6.1.1.
By Value & Volume
3
Table of Contents S. No.
Contents 6.2.
6.3.
Page No.
Market Share & Forecast 6.2.1.
By Therapy
6.2.2.
By Type
6.2.3.
By Application
6.2.4.
By Therapeutics
6.2.5.
By Route of Administration
6.2.6.
By End-User
6.2.7.
By Country
Asia-Pacific: Country Analysis
6.3.1.
China Nuclear Medicine Market Outlook 6.3.1.1.
Market Size & Forecast 6.3.1.1.1.
6.3.1.2.
6.3.2.
By Value & Volume
Market Share & Forecast 6.3.1.2.1.
By Therapy
6.3.1.2.2.
By Type
6.3.1.2.3.
By Application
6.3.1.2.4.
By Therapeutics
6.3.1.2.5.
By Route of Administration
6.3.1.2.6.
By End-User
India Nuclear Medicine Market Outlook
4
Table of Contents S. No.
Contents 6.3.2.1.
Market Size & Forecast 6.3.2.1.1.
6.3.2.2.
6.3.3.
By Value & Volume
Market Share & Forecast
6.3.2.2.1.
By Therapy
6.3.2.2.2.
By Type
6.3.2.2.3.
By Application
6.3.2.2.4.
By Therapeutics
6.3.2.2.5.
By Route of Administration
6.3.2.2.6.
By End-User
Japan Nuclear Medicine Market Outlook 6.3.3.1.
Market Size & Forecast 6.3.3.1.1.
6.3.3.2.
6.3.4.
Page No.
By Value & Volume
Market Share & Forecast 6.3.3.2.1.
By Therapy
6.3.3.2.2.
By Type
6.3.3.2.3.
By Application
6.3.3.2.4.
By Therapeutics
6.3.3.2.5.
By Route of Administration
6.3.3.2.6.
By End-User
South Korea Nuclear Medicine Market Outlook
5
Table of Contents S. No.
Contents 6.3.4.1.
Market Size & Forecast 6.3.4.1.1.
6.3.4.2.
6.3.5.
Page No.
By Value & Volume
Market Share & Forecast 6.3.4.2.1.
By Therapy
6.3.4.2.2.
By Type
6.3.4.2.3.
By Application
6.3.4.2.4.
By Therapeutics
6.3.4.2.5.
By Route of Administration
6.3.4.2.6.
By End-User
Australia Nuclear Medicine Market Outlook 6.3.5.1.
Market Size & Forecast 6.3.5.1.1.
6.3.5.2.
By Value & Volume
Market Share & Forecast
6.3.5.2.1.
By Therapy
6.3.5.2.2.
By Type
6.3.5.2.3.
By Application
6.3.5.2.4.
By Therapeutics
6.3.5.2.5.
By Route of Administration
6.3.5.2.6.
By End-User
6
Table of Contents S. No.
Contents 6.3.6.
Singapore Nuclear Medicine Market Outlook 6.3.6.1.
Market Size & Forecast 6.3.6.1.1.
6.3.6.2.
7.
Page No.
By Value & Volume
Market Share & Forecast 6.3.6.2.1.
By Therapy
6.3.5.2.2.
By Type
6.3.6.2.3.
By Application
6.3.6.2.4.
By Therapeutics
6.3.6.2.5.
By Route of Administration
6.3.6.2.6.
By End-User
Europe Nuclear Medicine Market Outlook 7.1.
Market Size & Forecast 7.1.1.
7.2.
By Value & Volume
Market Share & Forecast 7.2.1.
By Therapy
7.2.2.
By Type
7.2.3.
By Application
7.2.4.
By Therapeutics
7.2.5.
By Route of Administration
7
Table of Contents S. No.
Contents
7.3.
7.2.6.
By End-User
7.2.7.
By Country
Page No.
Europe: Country Analysis 7.3.1.
France Nuclear Medicine Market Outlook 7.3.1.1.
Market Size & Forecast 7.3.1.1.1.
7.3.1.2.
7.3.2.
By Value & Volume
Market Share & Forecast 7.3.1.2.1.
By Therapy
7.3.1.2.2.
By Type
7.3.1.2.3.
By Application
7.3.1.2.4.
By Therapeutics
7.3.1.2.5.
By Route of Administration
7.3.1.2.6.
By End-User
Germany Nuclear Medicine Market Outlook 7.3.2.1.
Market Size & Forecast
7.3.2.1.1. 7.3.2.2.
By Value & Volume
Market Share & Forecast 7.3.2.2.1.
By Therapy
8
Table of Contents S. No.
Contents
7.3.3.
7.3.2.2.2.
By Type
7.3.2.2.3.
By Application
7.3.2.2.4.
By Therapeutics
7.3.2.2.5.
By Route of Administration
7.3.2.2.6.
By End-User
United Kingdom Nuclear Medicine Market Outlook 7.3.3.1.
Market Size & Forecast 7.3.3.1.1.
7.3.3.2.
7.3.4.
Page No.
By Value & Volume
Market Share & Forecast 7.3.3.2.1.
By Therapy
7.3.3.2.2.
By Type
7.3.3.2.3.
By Application
7.3.3.2.4.
By Therapeutics
7.3.3.2.5.
By Route of Administration
7.3.3.2.6.
By End-User
Italy Nuclear Medicine Market Outlook 7.3.4.1.
Market Size & Forecast 7.3.4.1.1.
7.3.4.2.
By Value & Volume
Market Share & Forecast 7.3.4.2.1.
By Therapy
7.3.4.2.2.
By Type
7.3.4.2.3.
By Application
9
Table of Contents S. No.
Contents
7.3.5.
7.3.4.2.4.
By Therapeutics
7.3.4.2.5.
By Route of Administration
7.3.4.2.6.
By End-User
Spain Nuclear Medicine Market Outlook 7.3.5.1.
Market Size & Forecast 7.3.5.1.1.
7.3.5.2.
7.3.6.
Page No.
By Value & Volume
Market Share & Forecast
7.3.5.2.1.
By Therapy
7.3.5.2.2.
By Type
7.3.5.2.3.
By Application
7.3.5.2.4.
By Therapeutics
7.3.5.2.5.
By Route of Administration
7.3.5.2.6.
By End-User
Russia Nuclear Medicine Market Outlook 7.3.6.1.
Market Size & Forecast 7.3.6.1.1.
7.3.6.2.
By Value & Volume
Market Share & Forecast 7.3.6.2.1.
By Therapy
7.3.6.2.2.
By Type
7.3.6.2.3.
By Application
7.3.6.2.4.
By Therapeutics
7.3.6.2.5.
By Route of Administration
10
Table of Contents S. No.
Contents 7.3.6.2.6.
8.
Page No.
By End-User
North America Nuclear Medicine Market Outlook 8.1.
Market Size & Forecast 8.1.1.
8.2.
8.3.
By Value & Volume
Market Share & Forecast 8.2.1.
By Therapy
8.2.2.
By Type
8.2.3.
By Application
8.2.4.
By Therapeutics
8.2.5.
By Route of Administration
8.2.6.
By End-User
8.2.7.
By Country
North America: Country Analysis 8.3.1.
United States Nuclear Medicine Market Outlook 8.3.1.1.
Market Size & Forecast 8.3.1.1.1.
8.3.1.2.
By Value & Volume
Market Share & Forecast 8.3.1.2.1.
By Therapy
8.3.1.2.2.
By Type
8.3.1.2.3.
By Application
8.3.1.2.4.
By Therapeutics
8.3.1.2.5.
By Route of Administration
8.3.1.2.6.
By End-User
11
Table of Contents S. No.
Contents 8.3.2.
Mexico Nuclear Medicine Market Outlook 8.3.2.1.
Market Size & Forecast 8.3.2.1.1.
8.3.2.2.
8.3.3.
By Value & Volume
Market Share & Forecast 8.3.2.2.1.
By Therapy
8.3.2.2.2.
By Type
8.3.2.2.3.
By Application
8.3.2.2.4.
By Therapeutics
8.3.2.2.5.
By Route of Administration
8.3.2.2.6.
By End-User
Canada Nuclear Medicine Market Outlook 8.3.2.1.
Market Size & Forecast 8.3.2.1.1.
8.3.2.2.
9.
Page No.
By Value & Volume
Market Share & Forecast 8.3.2.2.1.
By Therapy
8.3.2.2.2.
By Type
8.3.2.2.3.
By Application
8.3.2.2.4.
By Therapeutics
8.3.2.2.5.
By Route of Administration
8.3.2.2.6.
By End-User
South America Nuclear Medicine Market Outlook 9.1.
Market Size & Forecast 9.1.1.
By Value & Volume
12
Table of Contents S. No.
Contents 9.2.
9.3.
Page No.
Market Share & Forecast 9.2.1.
By Therapy
9.2.2.
By Type
9.2.3.
By Application
9.2.4.
By Therapeutics
9.2.5.
By Route of Administration
9.2.6.
By End-User
9.2.7.
By Country
South America: Country Analysis 9.3.1.
Brazil Nuclear Medicine Market Outlook 9.3.1.1.
Market Size & Forecast 9.3.1.1.1
9.3.1.2.
9.3.2.
By Value & Volume
Market Share & Forecast 9.3.1.2.1.
By Therapy
9.3.1.2.2.
By Type
9.3.1.2.3.
By Application
9.3.1.2.4.
By Therapeutics
9.3.1.2.5.
By Route of Administration
9.3.1.2.6.
By End-User
Argentina Nuclear Medicine Market Outlook 9.3.2.1.
Market Size & Forecast
9.3.2.1.1
By Value & Volume
13
Table of Contents S. No.
Contents 9.3.2.2.
9.3.3.
Market Share & Forecast 9.3.2.2.1.
By Therapy
9.3.2.2.2.
By Type
9.3.2.2.3.
By Application
9.3.2.2.4.
By Therapeutics
9.3.2.2.5.
By Route of Administration
9.3.2.2.6.
By End-User
Colombia Nuclear Medicine Market Outlook 9.3.3.1.
Market Size & Forecast 9.3.3.1.1
9.3.3.2.
10.
Page No.
By Value & Volume
Market Share & Forecast 9.3.3.2.1.
By Therapy
9.3.2.2.2.
By Type
9.3.2.2.3.
By Application
9.3.2.2.4.
By Therapeutics
9.3.2.2.5.
By Route of Administration
9.3.2.2.6.
By End-User
Middle East & Africa Nuclear Medicine Market Outlook 10.1.
Market Size & Forecast 10.1.1.
10.2.
By Value & Volume
Market Share & Forecast 10.2.1.
By Therapy
10.2.2.
By Type
14
Table of Contents S. No.
Contents
10.3.
10.2.3.
By Application
10.2.4.
By Therapeutics
10.2.5.
By Route of Administration
10.2.6.
By End-User
10.2.7.
By Country
Page No.
Middle East & Africa : Country Analysis 10.3.1.
South Africa Nuclear Medicine Market Outlook 10.3.1.1.
Market Size & Forecast 10.3.1.1.1.
10.3.1.2.
10.3.2.
By Value & Volume
Market Share & Forecast 10.3.1.2.1.
By Therapy
10.3.1.2.2.
By Type
10.3.1.2.3.
By Application
10.3.1.2.4.
By Therapeutics
10.3.1.2.5.
By Route of Administration
10.3.1.2.6.
By End-User
Saudi Arabia Nuclear Medicine Market Outlook 10.3.2.1.
Market Size & Forecast 10.3.2.1.1.
10.3.2.2.
By Value & Volume
Market Share & Forecast 10.3.2.2.1.
By Therapy
15
Table of Contents S. No.
Contents
10.3.3.
10.3.2.2.2.
By Type
10.3.2.2.3.
By Application
10.3.2.2.4.
By Therapeutics
10.3.2.2.5.
By Route of Administration
10.3.2.2.6.
By End-User
UAE Nuclear Medicine Market Outlook 10.3.3.1.
Market Size & Forecast 10.3.3.1.1.
10.3.3.2.
11.
Page No.
By Value & Volume
Market Share & Forecast 10.3.3.2.1.
By Therapy
10.3.3.2.2.
By Type
10.3.3.2.3.
By Application
10.3.3.2.4.
By Therapeutics
10.3.3.2.5.
By Route of Administration
10.3.3.2.6.
By End-User
Market Dynamics 11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
13.
Competitive Landscape (Top Global Players)
14.
Strategic Recommendations
15.
About Us & Disclaimer
16
RESEARCH METHODOLOGY
Research Methodology
Market Profiling
In-depth secondary research was conducted to determine top players in the global nuclear medicine market, overall market size and segmental market size.
Formulating Questionnaire
In order to conduct industry experts’ interviews, TechSci formulated a detailed discussion guide.
Developing List of Respondents
Data Collection
Data Validation
Data obtained as a result of primary and secondary research was validated through rigorous triangulation.
TechSci conducted interviews with industry experts and industry players for data collection and verification.
List of industry players and industry specialists was developed.
Primary Research
Data Collection
Data Filter & Analysis
Research & Intelligence
Actionable Insights
Business Solution
LinkedIn TechSci Internal Database
✓ Recent Developments ✓ Market Changing Aspects/Dynamics ✓ Government Policies ✓ Conclusion
✓ Identifying Key Opinion Leaders ✓ Questionnaire Design ✓ In-depth Interviews
Primary Research ✓ ✓
Desk Research
Secondary Research ✓ ✓ ✓ ✓ ✓ ✓ ✓
Company Websites Company Annual Reports White Paper Study Financial Reports Investor Presentations Regulatory Body Associations, etc.
Data Analysis
The data was scrutinized using MS-Excel, statistical tools and internal proprietary database to obtain qualitative and quantitative insights about the global nuclear medicine market.
Company Analysis ✓ Market Participants ✓ Key Strengths
Paid Sources
✓ ✓
Factiva Hoovers
18
Research Methodology Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global nuclear medicine market. The team has analyzed the
outlook of various segments of this market, while considering the major influencing factors such as increasing research and development activities in radiotherapy to treat various diseases and increasing prevalence of diseases like cancer, among others. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in the global nuclear medicine market.
Methodology Followed for Calculation of Market Size:
•
Market Size by Value & Volume: Market size, in terms of value & volume, for the year 2019 was calculated based on information collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as hospitals, oncology centers, market influencers & end users, industry experts, and other industry participants.
•
The team interviewed more than 15 – 20 oncology centers & hospitals, 100 – 120 end users, 15 – 20 industry experts and other value chain stakeholders in the global nuclear medicine market to obtain the overall market size from 2015 to 2019, which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during 2015-2019.
19
Research Methodology •
Respondents were asked about the current and future market growth rates, market shares by therapy, by type, by application, by therapeutics, by route of administration, by end-user, by each region, and by company. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares: •
Market shares shares by therapy, by type, by application, by therapeutics, by route of administration, by end-user, by each region, and by company were calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of nuclear medicine market. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting: •
TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.
•
Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global nuclear medicine market, TechSci Research used various forecast techniques such as: ✓
Moving Average
✓
Time Series Analysis
✓
Regression Analysis
✓
Econometric and Judgmental Analysis
20
Research Methodology TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million. Partial List of Companies Interviewed
▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪
Cardinal Health Curium Lantheus Bracco Advanced Accelerator Applications NTP Radioisotopes Eckert & Ziegler Jubilant DraxImage GE Healthcare Inc. Siemens Healthineers Rotem Industries Eczacibasi-Monrol IBA Group Ire-Elit Lucerno Dynamics Positron Corporation NorthStar Medical Radioisotopes Pharmalucence Norgine Roche
Key Secondary Sources
▪ World Bank ▪ TechSci Research Proprietary Database & Knowledge Repository ▪ Company Annual Reports ▪ Industry Magazines ▪ Industry Reports ▪ News Dailies ▪ Credible Paid Databases
21
INDUSTRY BRIEF According to TechSci Research report, “Global Nuclear Medicine Market By Therapy (Radioactive Iodine, Radioactive Antibodies, Others), By Type (SPECT, PET, Alpha-emitters, Beta-emitters, Brachytherapy), By Application (Cardiology, Respiratory, Orthopaedics, Others),
By Therapeutics (Alpha Particle Emitters, Beta Particle Emitters, Others), By Route of Administration (Oral,
Intravenous, Nasal), By End-User (Hospitals, Diagnostic Centers, Others), By Region, Forecast & Opportunities, 2025”, the market is expected to grow at a robust CAGR during forecast period owing to factors like rising incidence and prevalence of cancer and cardiovascular diseases and rising awareness about nuclear medicine. Additionally, conventional chemotherapy treatments are being replaced by therapeutic radiopharmaceuticals for oncology and cancer treatment due to their greater convenience. This is further propelling the growth of global nuclear medicine market. Additionally,
nuclear Medicines works as a convenient and safer alternative for patients when compared to X-Rays and other external radiation imaging devices. Due to this, physicians nowadays are preferring nuclear medicines, which are also known as radiopharmaceuticals. Application of nuclear medicines has also helped in improving pediatric survival rate globally and hence are getting accepted widely. Moreover, advancements in radiotracers and advent of alpha radioimmunotherapy (Rit)-based targeted cancer treatments are also creating high demand for nuclear medicines. Expanding usage across neurological applications are likely to benefit nuclear medicine manufacturing companies. However, there are certain issues which nuclear medicine market faces. Lack of patient and physician education and awareness proves as a challenge for the market. Also, competition from other
imaging modalities makes the nuclear medicine market highly competitive. The rival imaging modalities have been successful in being accepted among medical practitioners. The global nuclear medicine market is segmented based on therapy, type, application, therapeutics, route of administration, end-user and region. Based on type, the global nuclear medicine market is segmented into SPECT, PET, Alpha-emitters, Beta-emitters and Brachytherapy. Among them, the alpha-emitters nuclear medicines are projected to hold largest market share during the forecast period owing to its targeted properties over other types. Major players operating in the global nuclear medicine market inlude Cardinal Health, Curium, Lantheus, Bracco, Advanced Accelerator Applications, NTP Radioisotopes, Eckert & Ziegler, Jubilant DraxImage, GE Healthcare, Siemens Healthineers, Rotem Industries, Eczacibasi-Monrol, IBA Group, Ire-Elit, Lucerno Dynamics, Positron Corporation, NorthStar Medical Radioisotopes, Pharmalucence, Norgine, Roche, etc. Key players are implementing multiple strategies to maintain their significant share in the global nuclear medicine market. These strategies include mergers & acquisition, product developments, business expansion and collaborative development. “Exponential growth in the healthcare industry is expected to fuel the nuclear medicine market across the globe. Increasing investment for research and development of nuclear medicine is going to pen myriad opportunities for the companies. However, nuclear medicines are not cost effective hence the market is relatively constrained. Some major steps which can be taken to boost the market
could be educating medical practitioners and patients about the benefits of nuclear medicines,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
22
SAMPLE DATA - SNAPSHOT Global Nuclear Medicine Market Size, By Value (USD Million) & By Volume (Million Units), 2015–2025F
6.00
5.00
20.00
10.00
8.00
7.00
40.00
30.00
CAGR By Value & Volume
2015
XX%
9.00 50.00
2019
10.00 60.00
11.00 70.00
13.00
12.00
90.00
80.00
14.00 100.00
CAGR By Value & Volume
2020E
110.00
2025F
YY%
By Value (USD Million)
15.00
By Volume (Million Units)
North America Nuclear Medicine Market Share, By Therapy, By Value, 2015–2025F Radioactive Iodine
Radioactive Antibodies
30% 30% 30% 30% 30% 30% 30% 30% 30% 30% 30%
2025F 2024F 2023F 2022F 2021F 2020E 2019 2018 2017 2016 2015
Radioactive Phosphorus
20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
Other Radioactive Substances
30% 30% 30% 30% 30% 30% 30% 30% 30% 30% 30%
20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
United States Nuclear Medicine Market Share, By Type, By Value, 2015–2025F SPECT 2025F 2024F 2023F 2022F 2021F 2020E 2019 2018 2017 2016 2015
PET
30% 30% 30% 30% 30% 30% 30% 30% 30% 30% 30%
Alpha-emitters
20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
Beta-emitters
20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
Brachytherapy
20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
10% 10% 10% 10% 10% 10% 10% 10% 10% 10% 10%
23
REPORT ORDERING
REPORT NAME : GLOBAL NUCLEAR MEDICINE MARKET FORECAST & OPPORTUNITIES 2015 – 2025
License Type
Price
Single User License
$4450
Multi-User License
$5450
Custom Research License
$9450
To View Sample OR Purchase Report
24
About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas
to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports •
Global Portable Ventilator Market, By Type (Invasive Ventilation, Non-Invasive Ventilation), By Mode (Pressure Mode Ventilation; Volume Mode Ventilation; Combined Mode Ventilation), By Application (Aeromedical; Pediatrics; Domiciliary Ventilation; Non-Invasive Ventilation), By End User (Hospital; Ambulance; Clinic; Rehabilitation Center; Others), By Region, Forecast & Opportunities, 2025
•
Global Biomedical Refrigerators and Freezers Market, By Product (Pass-Through, Explosion Safe, Flammable storage, Combo/Dual Temperature, Others), By Storage (Blood, Vaccines, Plasma, DNA, Flammable chemicals, Others), By Temperature (RNA & DNA, Vaccines), By Capacity (138L, 169L, 221L, 230L, 426L, 690L, Others), By End-user (Hospitals, Pharmacies, Diagnostic Centers, Research Laboratories, Blood Banks), By Region, Forecast & Opportunities, 2025 TechSci Research – North America 708 Third Avenue, Manhattan, New York, United States Tel: +1- 646- 360- 1656 Email: sales@techsciresearch.com www.techsciresearch.com
TechSci Research – Europe
54, Old brook, Bretton, Peterborough, United Kingdom Email: sales@techsciresearch.com www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital Region, U.P. - India Tel: +91-120-4523900 Email: sales@techsciresearch.com www.techsciresearch.com
Disclaimer The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.